Latest Period
Q1 2026
Security Snapshot
Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) Institutional Ownership
CUSIP: 64134X201
13F Institutional Holders and Ownership History from Q3 2023 to Q1 2026
Institutions Reporting
26
Shares (Excl. Options)
2,040,078
Price
$7.40
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- NRXS on NYSE
- Shares outstanding
- 11,508,976
- Price per share
- $7.00
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 2,040,078
- Total reported value
- $14,673,144
- % of total 13F portfolios
- 0%
- Share change
- +335,353
- Value change
- +$2,520,490
- Number of holders
- 26
- Price from insider filings
- $7.00
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- NRXS - Neuraxis, INC - Common Stock, par value $0.001 per share is tracked under CUSIP 64134X201.
- 26 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 18 to 26 between Q4 2025 and Q1 2026.
- Reported value moved from $6,880,388 to $14,673,144.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 26 institutions filings for Q1 2026.
Security key
64134X201
Latest holder period
Q1 2026
13F holders
26
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
NRXS full holder history
Neuraxis, INC SEC filings
Neuraxis, INC company facts
Neuraxis, INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 64134X201:
Significant Owners of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Hannasch Brian | 12% | +56% | $3,387,347 | +$1,274,446 | 1,144,374 | +60% | Brian P. Hannasch | 01 Jul 2025 |
| BIGGER CAPITAL FUND L P | 6.6% | -28% | $5,655,050 | -$1,574,454 | 764,196 | -22% | Bigger Michael | 31 Mar 2026 |
As of 31 Mar 2026, 26 institutional investors reported holding 2,040,078 shares of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS). This represents 18% of the company’s total 11,508,976 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) together control 18% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| AIGH Capital Management LLC | 3.5% | 400,000 | 0% | 0.61% | $2,960,000 |
| Rosalind Advisors, Inc. | 2.5% | 286,138 | 0% | 0.69% | $1,693,937 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2% | 225,867 | 0% | 0% | $1,671,416 |
| MONEY CONCEPTS CAPITAL CORP | 2% | 225,555 | +1.3% | 0.09% | $1,669,107 |
| Panoramic Capital, LLC | 1.7% | 190,000 | +15% | 0.99% | $1,406,000 |
| PARSONS CAPITAL MANAGEMENT INC/RI | 1% | 116,726 | 0% | 0.04% | $863,773 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.81% | 93,105 | +23% | 0% | $689,248 |
| MARSHALL WACE, LLP | 0.68% | 78,695 | 0% | $582,343 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.67% | 76,954 | 0% | $569,460 | |
| VANGUARD FIDUCIARY TRUST CO | 0.45% | 51,887 | 0% | 0% | $383,964 |
| Centiva Capital, LP | 0.44% | 50,833 | 0.02% | $376,164 | |
| UBS Group AG | 0.39% | 45,342 | -7.1% | 0% | $335,531 |
| STATE STREET CORP | 0.33% | 38,537 | +26% | 0% | $285,174 |
| T3 Companies, LLC | 0.26% | 29,921 | 0.3% | $221,415 | |
| BlackRock, Inc. | 0.24% | 27,354 | 0% | $202,420 | |
| NORTHERN TRUST CORP | 0.16% | 18,283 | -12% | 0% | $135,294 |
| Wealthcare Advisory Partners LLC | 0.13% | 15,188 | 0% | 0% | $112,391 |
| ELEVATION POINT WEALTH PARTNERS, LLC | 0.1% | 11,000 | 0% | $81,400 | |
| Vestmark Advisory Solutions, Inc. | 0.1% | 11,000 | 0% | $81,400 | |
| ROYAL BANK OF CANADA | 0.09% | 10,101 | -33% | 0% | $75,000 |
| HRT FINANCIAL LP | 0.09% | 10,010 | 0% | $74,000 | |
| LPL Financial LLC | 0.09% | 10,000 | 0% | 0% | $74,000 |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 0.09% | 10,000 | 0.01% | $74,000 | |
| MORGAN STANLEY | 0.05% | 5,802 | 0% | 0% | $42,935 |
| Ulland Investment Advisors, LLC | 0.01% | 1,000 | 0% | 0.01% | $7,000 |
Institutional Holders of Neuraxis, INC - Common Stock, par value $0.001 per share (NRXS) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 2,040,078 | $14,673,144 | +$2,520,490 | $7.40 | 26 |
| 2025 Q4 | 1,572,533 | $6,880,388 | +$3,297,217 | $4.54 | 18 |
| 2025 Q3 | 809,096 | $2,492,424 | +$6,434 | $3.08 | 18 |
| 2025 Q2 | 844,510 | $2,043,750 | -$4,406 | $2.42 | 17 |
| 2025 Q1 | 919,586 | $1,976,640 | +$1,116,841 | $2.15 | 13 |
| 2024 Q4 | 399,929 | $939,346 | +$339,534 | $2.35 | 12 |
| 2024 Q3 | 255,447 | $789,543 | +$461,812 | $2.98 | 9 |
| 2024 Q2 | 110,906 | $308,337 | +$100,958 | $2.78 | 10 |
| 2024 Q1 | 74,589 | $232,603 | -$2,973 | $3.12 | 8 |
| 2023 Q4 | 75,542 | $201,377 | +$24,651 | $2.67 | 7 |
| 2023 Q3 | 54,474 | $207,201 | +$207,201 | $3.80 | 6 |